NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/18/2026 13:40
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization20.41 mln
Float18.87 mln
Earnings Date08/28/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-4.78
Highly reliable
Relative Strength
81
/ 100
Strongly outperforming
Debt / Equity
-1.08
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Celularity Inc. is a New Jersey-based medical company founded in 1998 that develops treatments for aging and degenerative conditions using cells and tissues derived from human placentas. Its product pipeline targets diseases such as Crohn's disease, diabetic foot ulcers, muscular dystrophy, and osteoarthritis, while its commercial portfolio includes wound care and surgical products sold under several brand names. The company also runs a biobanking service through LifebankUSA, collecting and storing umbilical cord and placental material after birth, and works alongside partners including Regeneron Pharmaceuticals and Sorrento Therapeutics to advance its research.
